English | Español

Community
+ Community
Ruth de Jauregui | Jun 4, 2017

Advaxis, Bristol-Myers Squibb to collaborate in metastatic cervical cancer study
+ Community
Erianne Leatherman | Jun 4, 2017

Revision to heart failure guideline released
+ Technology/Innovation
Ruth de Jauregui | Jun 4, 2017

National Institute of Health announces promising influenza study tool
+ Regulatory
Carrice Quinnie | Jun 4, 2017

Merck enters exclusive license agreement with Teijin Pharma
+ Regulatory
Robert Hadley | Jun 4, 2017

AstraZeneca to reveal results of three cancer-fighting drugs at ASCO meeting
+ Community
Ruth de Jauregui | Jun 4, 2017

American Heart Association praises CMS for approving therapy for peripheral artery disease
+ Regulatory
Robert Hadley | Jun 4, 2017

Merck’s targeted tumor drug approved for colorectal and other cancers
+ Regulatory
Robert Hadley | Jun 3, 2017

FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes